Tobacco News and Research

RSS

FDA approves Uptravi tablets to treat adults with pulmonary arterial hypertension

On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation.

22 Dec 2015

FDA updates blood donor deferral recommendations to help ensure continued safety of blood supply

Today, the U.S. Food and Drug Administration issued final guidance outlining updated blood donor deferral recommendations to reflect the most current scientific evidence and to help ensure continued safety of the blood supply by reducing the risk of human immunodeficiency virus (HIV) transmission by blood and blood products.

22 Dec 2015

Smokers who see graphic warning labels on cigarette packs have more negative feelings about smoking

A new study is the first to provide real-world evidence of the effectiveness of smoking warning labels that include graphic photos of the damage caused by regular tobacco use.

22 Dec 2015

Teens with moderate mental health problems vape e-cigarettes

Teenagers with moderate mental health problems who may not have considered smoking conventional cigarettes are turning to electronic cigarettes, a new USC study has found.

20 Dec 2015

FDA approves Fenix Continence Restoration System to treat fecal incontinence

The U.S. Food and Drug Administration today approved the Fenix Continence Restoration System to treat fecal incontinence in patients who are not candidates for, or have previously failed, medical or other surgical options.

20 Dec 2015

Smoking bans may stop casual smokers from becoming heavy smokers

If governments want to discourage smoking among young people, both high taxes and smoking bans do the job - but bans may have one key advantage.

18 Dec 2015

LifeVest wearable cardioverter defibrillator approved for children at risk for sudden cardiac arrest

The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent.

17 Dec 2015

Drug use remains stable among teens, MTF survey shows

The 2015 Monitoring the Future survey (MTF) shows decreasing use of a number of substances, including cigarettes, alcohol, prescription opioid pain relievers, and synthetic cannabinoids ("synthetic marijuana"). Other drug use remains stable, including marijuana, with continued high rates of daily use reported among 12th graders, and ongoing declines in perception of its harms.

17 Dec 2015

Basaglar (insulin glargine injection) approved to improve glycemic control in diabetes patients

The U.S. Food and Drug Administration today approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

17 Dec 2015

Revolutionary new app can capture accurate global cause of death data

Researchers have developed a revolutionary new app to capture accurate global cause of death data on tablets and mobile phones.

16 Dec 2015

Bile acid may help treat fatty liver disease and obesity

A bile acid that can turn off a receptor in the gut has prevented and reversed fatty liver disease in mice, according to an international team of researchers. The compound may help treat certain metabolic disorders, such as Type 2 diabetes and obesity, as well.

16 Dec 2015

Bridion injection approved to reverse effects of neuromuscular blocking drugs used during certain types of surgery

The U.S. Food and Drug Administration today approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults.

16 Dec 2015

ATS Tobacco Action Committee supports regulation to curb exposure to health risks associated with tobacco products

The U.S. Food and Drug Administration is expected issue its final ruling soon on the regulation of all tobacco products, including cigars and e-cigarettes, two of the largest sources of unregulated tobacco in the U.S.

14 Dec 2015

Review provides recommendations to improve cancer screening, treatment in people with mental illness

A new report calls attention to cancer in people with mental illness, suggesting that healthcare system and societal factors are just as critical as individual lifestyle factors-- linked to smoking and obesity--that lead to health disparities among this group.

12 Dec 2015

FDA approves Vistogard (uridine triacetate) for emergency treatment of chemotherapy overdose

The U.S. Food and Drug Administration today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.

12 Dec 2015

Alecensa (alectinib) approved for treatment of people with advanced ALK-positive NSCLC

The U.S. Food and Drug Administration today approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-small cell lung cancer (NSCLC) whose disease has worsened after, or who could not tolerate treatment with, another therapy called Xalkori (crizotinib).

11 Dec 2015

Employers pay billions of dollars for health care tied to unhealthy lifestyle choices

One out of every four dollars employers pay for health care is tied to unhealthy lifestyle choices or conditions like smoking, stress and obesity, despite the fact that most large employers have workplace wellness programs.

11 Dec 2015

CAMH survey finds risky drinking behaviour among Ontario students

Alcohol remains the most popular drug of choice for Ontario students in grades 7 through 12, with 29 percent of 12th graders engaging in hazardous drinking, according to the 2015 Ontario Student Drug Use and Health Survey (OSDUHS) released today by the Centre for Addiction and Mental Health.

10 Dec 2015

FDA clears for marketing first cooling cap to reduce chemotherapy-induced hair loss

Today, the U.S. Food and Drug Administration cleared for marketing in the United States the first cooling cap to reduce hair loss (alopecia) in female breast cancer patients undergoing chemotherapy.

9 Dec 2015

Flavoring chemicals in e-cigarettes linked to severe respiratory disease

Diacetyl, a flavoring chemical linked to cases of severe respiratory disease, was found in more than 75% of flavored electronic cigarettes and refill liquids tested by researchers at Harvard T.H. Chan School of Public Health.

8 Dec 2015

Tobacco News and Research

FDA approves Uptravi tablets to treat adults with pulmonary arterial hypertension

FDA updates blood donor deferral recommendations to help ensure continued safety of blood supply

Smokers who see graphic warning labels on cigarette packs have more negative feelings about smoking

Teens with moderate mental health problems vape e-cigarettes

FDA approves Fenix Continence Restoration System to treat fecal incontinence

Smoking bans may stop casual smokers from becoming heavy smokers

LifeVest wearable cardioverter defibrillator approved for children at risk for sudden cardiac arrest

Drug use remains stable among teens, MTF survey shows

Basaglar (insulin glargine injection) approved to improve glycemic control in diabetes patients

Revolutionary new app can capture accurate global cause of death data

Bile acid may help treat fatty liver disease and obesity

Bridion injection approved to reverse effects of neuromuscular blocking drugs used during certain types of surgery

ATS Tobacco Action Committee supports regulation to curb exposure to health risks associated with tobacco products

Review provides recommendations to improve cancer screening, treatment in people with mental illness

FDA approves Vistogard (uridine triacetate) for emergency treatment of chemotherapy overdose

Alecensa (alectinib) approved for treatment of people with advanced ALK-positive NSCLC

Employers pay billions of dollars for health care tied to unhealthy lifestyle choices

CAMH survey finds risky drinking behaviour among Ontario students

FDA clears for marketing first cooling cap to reduce chemotherapy-induced hair loss

Flavoring chemicals in e-cigarettes linked to severe respiratory disease

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News